Project Grant HT94252510984
Award Date 11/15/25
Completion Date 11/14/27
Dollars Obligated $309K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Omaha, NE 68105, USA
Similar Awards
- The Defense Health Agency awarded a $602,814 Project Grant to the University of Nebraska Medical Center (UNMC) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from November 1, 2024 to October 31, 2027, supports research to investigate "Targeting Extracellular Nucleoside Metabolism as a Strategy to Potentiate the Effects of Immunotherapy in Pancreatic Ductal Adenocarcinoma." The project aims to explore innovative approaches...
- This $602,550 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) supports adoptive cellular therapy research for pancreatic cancer. The awardee, the University of Nebraska Medical Center (UNMC), will conduct innovative biomedical research to develop novel therapeutic approaches, perform clinical trials, and provide technical expertise in this critical medical field. As a prominent academic research...
- This Project Grant award, valued at $2,000,000.00 and running from June 1, 2025 to May 31, 2028, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports advanced biomedical research at the University of Nebraska Medical Center (UNMC) aimed at investigating the interrelationship between the PINK1-PRKN pathway disruption and tauopathy in the pathophysiology of cognitive impairment in Parkinson's...
- The University of Nebraska Medical Center (UNMC) was awarded a $1,544,999.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a "NOVEL ER STRESS MITIGATION PATHWAY IN ERBB2-DRIVEN ONCOGENESIS". The grant, which has a performance period from May 1, 2024 to April 30, 2027, will support UNMC's investigation of an innovative pathway for mitigating endoplasmic reticulum (ER) stress in ErbB2-driven...
- The Department of the Army Medical Command, through the Military Medical Research and Development federal grant program (CFDA 12.420), awarded a $556,200.00 project grant to the University of Nebraska Medical Center (UNMC) for "ADOPTIVE CELLULAR THERAPY FOR PANCREATIC CANCER". The award, with a period of performance from October 1, 2024 to September 30, 2027, will fund advanced biomedical research to develop innovative treatments for pancreatic cancer. UNMC, a prominent academic...
- The University of Nebraska Medical Center (UNMC) has been awarded a $848,335 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding will support a 3-year research project focused on developing a novel therapeutic approach to prevent the progression of uveal melanoma, a rare and aggressive form of eye cancer. The research aims to transform healthcare for military service members, veterans, and the...
- The Defense Health Agency awarded a $579,375 Project Grant to the University of Nebraska Medical Center to support research targeting APE1 interaction with DNA G-quadruplex to prevent metastasis in triple-negative breast cancer. The grant is funded through the Military Medical Research and Development program (CFDA 12.420) and aims to transform health care for service members and the public through innovative biomedical research investigating medical solutions for the battlefield. The University...
- The Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center (UNMC) Division, was awarded a $183,220 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "TARGETING THE CCL17/CCR4 AXIS TO ERADICATE LUNG CANCER BRAIN METASTASIS," aims to support advanced biomedical research that transforms healthcare for military service members, veterans, and the broader public....
- The Defense Health Agency awarded a $579,375 Project Grant to the University of Nebraska Medical Center through the Military Medical Research and Development program (CFDA 12.420) to support research targeting APE1 interaction with DNA G-quadruplex to prevent metastasis in triple-negative breast cancer. The three-year award beginning December 30, 2022 will fund research by the University of Nebraska Medical Center to investigate medical solutions for metastatic breast cancer through innovative...
- The University of Nebraska Medical Center (UNMC) was awarded a $927,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research titled "TARGETING FGFR4 SIGNALING TO OVERCOME CHEMORESISTANCE IN OVARIAN CANCER". The grant has an award date of July 1, 2024 and an ultimate completion date of June 30, 2028. UNMC, a leading institution in health sciences education, innovative research, and patient care, will...